Elabela vs Relaxin-2 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Elabela (also called Apela or Toddler) is the second endogenous peptide ligand for the APJ receptor, discovered in 2013 independently through two approaches: as an essential zebrafish cardiac development factor (Toddler) and as a novel human APJ ligand (Elabela). Unlike apelin pe...
Calculate Elabela dose →Relaxin-2 (H2 Relaxin) is an endogenous peptide hormone of the insulin superfamily, best known for its roles in pregnancy physiology including cervical ripening, uterine quiescence, and connective tissue remodeling. Beyond reproduction, relaxin-2 is a systemic anti-fibrotic and v...
Calculate Relaxin-2 dose →| Parameter | Elabela | Relaxin-2 |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Research | Clinical |
| Half-Life | Short (minutes, estimated) | 10-15 min (plasma) |
| Typical Dose | 5-500 nmol/kg (animal) | 30-300 mcg/kg/day (IV) |
| Frequency | Variable | Continuous 48-hour infusion (trials) |
| Route | Subcutaneous, Intravenous | Intravenous (infusion) |
| FDA Status | Not approved | Not approved (Phase III completed) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.